June 10 (Reuters) - Eli Lilly (NYSE:LLY) and Co LLY.N :
* TRULICITY® (DULAGLUTIDE) SIGNIFICANTLY REDUCED MAJOR CARDIOVASCULAR EVENTS FOR BROAD RANGE OF PEOPLE WITH TYPE 2 DIABETES
* ELI LILLY CANADA INC - REWIND DATA SHOWED A CONSISTENT EFFECT IN PEOPLE WITH AND WITHOUT ESTABLISHED CARDIOVASCULAR DISEASE